Bruce Power to partner with Isogen, BWXT on isotopes production

The Bruce plant near Kincardine, Ontario. Photo: Bruce Power

Bruce Power announced on July 20 that it has signed a memorandum of understanding with Isogen, a joint venture of Framatome and Toronto-based Kinectrics, and BWXT ITG Canada to advance feasibility work for the production of molybdenum-99. Mo-99 is the radioisotope most commonly used in nuclear medicine for diagnostic imaging and the detection of disease, along with other medical isotopes that are growing in demand.